Paul Dagum

Founder & CEO

Paul Dagum, MD, PhD is a computer scientist, physician and entrepreneur with a track record of creating and launching products in three successful venture-backed companies. Dr. Dagum’s early pioneering research in dynamic Bayesian networks is in use in many modern day applications. He further developed and patented massively scalable algorithms for big data science in use by the world’s largest data companies, and created and patented the first ever digital measures of central nervous system function based on human-computer interaction patterns. Dr. Dagum led NSF and NIH grants while at Stanford University, published over 75 peer-review articles and book chapters in computer science and medicine, and was awarded over 25 patents. Dr. Dagum received an MSc in theoretical physics, PhD in theoretical computer science both from the University of Toronto and an MD from Stanford University.

Read More

Thomas Insel

Co-Founder & President

Thomas R. Insel, MD, a psychiatrist and neuroscientist, is a co-founder and President of Mindstrong Health. From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders. Prior to serving as NIMH Director, Dr. Insel was Professor of Psychiatry at Emory University where he was founding director of the Center for Behavioral Neuroscience in Atlanta. Most recently (2015 – 2017), he led the Mental Health Team at Verily (formerly Google Life Sciences) in South San Francisco, CA. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.

Read More

Richard Klausner

Co-Founder & Executive Chairman

Richard D. Klausner is founder and Director of Juno Therapeutics and founder and Director of GRAIL. He is the former Senior Vice President, Chief Medical Officer and Chief Opportunity Officer of Illumina. He currently chairs the Grand Challenges in Cancer program of Cancer Research UK. Previously, he has served as the Executive Director for Global Health of the Bill and Melinda Gates Foundation. Dr. Klausner was appointed by Presidents Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development, as well as a past president of the American Society of Clinical Investigation. He is a member of the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences.

Read More

General Catalyst Team